• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Satisfaction with physician recommendation for and information about genetic counseling among breast cancer patients.乳腺癌患者对医生推荐和遗传咨询信息的满意度。
Breast J. 2011 Jan-Feb;17(1):79-82. doi: 10.1111/j.1524-4741.2010.01027.x. Epub 2010 Dec 6.
2
Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.近期确诊的乳腺癌患者中BRCA1/2基因咨询的经历:一项质性研究
J Psychosoc Oncol. 2008;26(4):33-52. doi: 10.1080/07347330802359586.
3
Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.高危乳腺癌患者对BRCA基因咨询外科转诊信的回忆及反应。
Ann Surg Oncol. 2009 Jul;16(7):1973-81. doi: 10.1245/s10434-009-0479-4. Epub 2009 Apr 30.
4
Cognitive and psychological impact of BRCA genetic counseling in before and after definitive surgery breast cancer patients.BRCA 基因咨询对确诊手术前后乳腺癌患者认知和心理的影响。
Ann Surg Oncol. 2012 Dec;19(13):4003-11. doi: 10.1245/s10434-012-2460-x. Epub 2012 Jul 6.
5
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.BRCA1/BRCA2基因突变检测在新诊断乳腺癌患者中的应用。
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1003-7. doi: 10.1158/1055-9965.EPI-03-0545.
6
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
7
Referral and experience with genetic testing among women with early onset breast cancer.早发性乳腺癌女性的基因检测转诊及经验
Genet Test. 2005 Winter;9(4):301-5. doi: 10.1089/gte.2005.9.301.
8
Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.BRCA 基因检测和咨询在全国商业保险人群中的利用和结果:ABOUT 研究。
JAMA Oncol. 2015 Dec;1(9):1251-60. doi: 10.1001/jamaoncol.2015.3048.
9
Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.基于计算机的决策辅助工具对乳腺癌易感性基因检测的知识、认知及意愿的影响:一项随机对照试验。
JAMA. 2004 Jul 28;292(4):442-52. doi: 10.1001/jama.292.4.442.
10
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study.患者对简化 BRCA1/2 检测程序的高度满意度:一项前瞻性研究的长期结果。
Breast Cancer Res Treat. 2019 Jan;173(2):313-318. doi: 10.1007/s10549-018-5000-y. Epub 2018 Oct 11.

引用本文的文献

1
"I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.“我认为,他们的提供者进行简短的交谈就可以大有帮助”:卵巢癌患者和提供者对遗传检测障碍和促进因素的看法。
Support Care Cancer. 2021 May;29(5):2663-2677. doi: 10.1007/s00520-020-05779-1. Epub 2020 Sep 25.
2
Exploring Prostate Cancer Patients' Interest and Preferences for Receiving Genetic Risk Information About Cancer Aggressiveness.探索前列腺癌患者对接受癌症侵袭性遗传风险信息的兴趣和偏好。
Am J Mens Health. 2020 May-Jun;14(3):1557988320919626. doi: 10.1177/1557988320919626.
3
Systematic development of a training program for healthcare professionals to improve communication about breast cancer genetic counseling with low health literate patients.为医疗保健专业人员制定培训计划,以改善与低健康素养患者的乳腺癌遗传咨询沟通。
Fam Cancer. 2020 Oct;19(4):281-290. doi: 10.1007/s10689-020-00176-3.
4
Communication about genetic testing with breast and ovarian cancer patients: a scoping review.与乳腺癌和卵巢癌患者沟通基因检测:范围综述。
Eur J Hum Genet. 2019 Apr;27(4):511-524. doi: 10.1038/s41431-018-0310-4. Epub 2018 Dec 20.
5
Evaluation of a clinical genetics service--a quality initiative.临床遗传学服务评估——一项质量改进举措。
J Genet Couns. 2014 Oct;23(5):881-9. doi: 10.1007/s10897-014-9713-8. Epub 2014 Mar 21.
6
Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.卵巢癌、输卵管癌或原发性腹膜癌患者的遗传咨询和基因检测转诊时机。
Int J Gynecol Cancer. 2013 Jul;23(6):1016-21. doi: 10.1097/IGC.0b013e3182994365.
7
Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.在肿瘤护理环境中,对遗传性乳腺癌高危个体进行遗传风险评估。
Cancer Control. 2012 Oct;19(4):255-66. doi: 10.1177/107327481201900402.
8
Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer.我们是否过于谨慎了?一项针对近期被诊断患有乳腺癌的女性进行以治疗为导向的种系 BRCA 基因检测的体验和看法的定性研究。
Support Care Cancer. 2012 Nov;20(11):2949-58. doi: 10.1007/s00520-012-1427-6. Epub 2012 Mar 24.

本文引用的文献

1
Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale.癌症遗传咨询的患者满意度:遗传咨询满意度量表的心理测量分析
J Genet Couns. 2004 Aug;13(4):293-304. doi: 10.1023/b:jogc.0000035523.96133.bc.
2
Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.高危乳腺癌患者对BRCA基因咨询外科转诊信的回忆及反应。
Ann Surg Oncol. 2009 Jul;16(7):1973-81. doi: 10.1245/s10434-009-0479-4. Epub 2009 Apr 30.
3
Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.新诊断乳腺癌患者遗传性基因突变的遗传咨询与检测:现有文献综述及拟议的研究议程
Breast Cancer Res. 2008;10(6):216. doi: 10.1186/bcr2194. Epub 2008 Nov 28.
4
Experiences of genetic counseling for BRCA1/2 among recently diagnosed breast cancer patients: a qualitative inquiry.近期确诊的乳腺癌患者中BRCA1/2基因咨询的经历:一项质性研究
J Psychosoc Oncol. 2008;26(4):33-52. doi: 10.1080/07347330802359586.
5
Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.乳腺癌初次治疗期间参与遗传咨询和BRCA检测的障碍。
Genet Med. 2007 Nov;9(11):766-77. doi: 10.1097/gim.0b013e318159a318.
6
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.他莫昔芬与携带BRCA1和BRCA2基因者的对侧乳腺癌:最新进展
Int J Cancer. 2006 May 1;118(9):2281-4. doi: 10.1002/ijc.21536.
7
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.BRCA1/BRCA2基因突变检测在新诊断乳腺癌患者中的应用。
Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1003-7. doi: 10.1158/1055-9965.EPI-03-0545.
8
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.携带BRCA1和BRCA2基因的乳腺癌患者发生卵巢癌的风险。
Gynecol Oncol. 2005 Jan;96(1):222-6. doi: 10.1016/j.ygyno.2004.09.039.
9
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.携带BRCA1和BRCA2基因突变者的对侧乳腺癌
J Clin Oncol. 2004 Jun 15;22(12):2328-35. doi: 10.1200/JCO.2004.04.033.
10
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.双侧预防性乳房切除术可降低BRCA1和BRCA2基因突变携带者患乳腺癌的风险:PROSE研究小组。
J Clin Oncol. 2004 Mar 15;22(6):1055-62. doi: 10.1200/JCO.2004.04.188. Epub 2004 Feb 23.

乳腺癌患者对医生推荐和遗传咨询信息的满意度。

Satisfaction with physician recommendation for and information about genetic counseling among breast cancer patients.

机构信息

Moffitt Cancer Center, Tampa, FL 33612,USA.

出版信息

Breast J. 2011 Jan-Feb;17(1):79-82. doi: 10.1111/j.1524-4741.2010.01027.x. Epub 2010 Dec 6.

DOI:10.1111/j.1524-4741.2010.01027.x
PMID:21129092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4603559/
Abstract

To evaluate satisfaction with (a) the timing and strength of provider recommendation for and (b) information received prior to and during genetic counseling (GC) among breast cancer patients who attended GC before definitive surgery (BDS) or after definitive surgery (ADS). Satisfaction with provider recommendation for and information received about GC was evaluated among breast cancer patients who attended GC as part of their clinical care (n=51). There were no significant differences among breast cancer patients who attended GC BDS or ADS in satisfaction with when the physician referred them for GC, the strength of recommendation for GC, the amount of information provided about the GC, and the information received in GC. From a clinical perspective, the optimal time for attending GC may be BDS. Nevertheless, breast cancer patients appear satisfied with physician recommendation of and information related to GC, regardless of when they attend.

摘要

评估在接受明确手术(BDS)前或后(ADS)行遗传咨询(GC)的乳腺癌患者对(a)医生推荐 GC 的时间和力度和(b)GC 前和 GC 期间所获信息的满意度。对作为临床护理一部分而参加 GC 的 51 例乳腺癌患者进行 GC 推荐和 GC 信息的满意度评估。BDS 和 ADS 组的乳腺癌患者在接受医生推荐 GC 的时间、GC 推荐力度、GC 相关信息量和 GC 期间所获信息量等方面,均无显著差异。从临床角度看,BDS 时行 GC 可能更为理想。尽管如此,乳腺癌患者对医生推荐 GC 和提供 GC 相关信息的满意度似乎不受就诊时间影响。